Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,955 | 8 | 79.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,800 | 1 | 14.9% |
| Travel and Lodging | $693.78 | 2 | 3.7% |
| Food and Beverage | $274.65 | 5 | 1.5% |
| Education | $33.08 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PTC Therapeutics, Inc. | $8,600 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $4,185 | 3 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $3,283 | 7 | $0 (2024) |
| Ascendis Pharma Inc | $2,570 | 1 | $0 (2024) |
| Sarepta Therapeutics, Inc. | $85.00 | 1 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $18.50 | 1 | $0 (2017) |
| AbbVie, Inc. | $14.58 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,038 | 11 | Merck Sharp & Dohme LLC ($4,185) |
| 2023 | $2,885 | 2 | PTC Therapeutics, Inc. ($2,800) |
| 2022 | $5,800 | 3 | PTC Therapeutics, Inc. ($5,800) |
| 2019 | $14.58 | 1 | AbbVie, Inc. ($14.58) |
| 2017 | $18.50 | 1 | Endo Pharmaceuticals Inc. ($18.50) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Consulting Fee | Cash or cash equivalent | $1,627.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Travel and Lodging | Cash or cash equivalent | $385.20 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Travel and Lodging | Cash or cash equivalent | $308.58 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $93.80 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $28.93 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| 05/01/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $49.78 | General |
| 02/29/2024 | Ascendis Pharma Inc | — | Consulting Fee | Cash or cash equivalent | $2,570.00 | General |
| 01/10/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Consulting Fee | Cash or cash equivalent | $697.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/08/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2023 | PTC Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| 03/21/2023 | Sarepta Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $85.00 | General |
| 11/16/2022 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: DMD | ||||||
| 08/04/2022 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: DMD | ||||||
| 06/13/2022 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Consulting Fee | Cash or cash equivalent | $4,600.00 | General |
| Category: DMD | ||||||
| 12/12/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Education | In-kind items and services | $14.58 | General |
| Category: Endocrinology | ||||||
| 11/16/2017 | Endo Pharmaceuticals Inc. | SUPPRELIN LA (Drug) | Education | In-kind items and services | $18.50 | General |
| Category: ENDOCRINOLOGY | ||||||
About Dr. David Weber, MD
Dr. David Weber, MD is a Pediatric Endocrinology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1639355712.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Weber, MD has received a total of $18,757 in payments from pharmaceutical and medical device companies, with $10,038 received in 2024. These payments were reported across 18 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($14,955).
Practice Information
- Specialty Pediatric Endocrinology
- Other Specialties Pediatric Endocrinology
- Location Philadelphia, PA
- Active Since 01/18/2008
- Last Updated 01/28/2020
- Taxonomy Code 2080P0205X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639355712
Products in Payments
- EMFLAZA (Drug) $5,800
- WINREVAIR (Biological) $4,185
- SUPPRELIN LA (Drug) $18.50
- Lupron Depot (Drug) $14.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Philadelphia
Maria Vogiatzi, Md, MD
Pediatric Endocrinology — Payments: $350,818
Dr. Judith Ross, Md, MD
Pediatric Endocrinology — Payments: $138,423
Dr. Jake Kushner, M.d, M.D
Pediatric Endocrinology — Payments: $72,214
Andrew Bauer, M.d, M.D
Pediatric Endocrinology — Payments: $33,972
Vaneeta Bamba, Md, MD
Pediatric Endocrinology — Payments: $11,068
Rachana Shah, M.d, M.D
Pediatric Endocrinology — Payments: $3,517